FKB-001

FKB‑001 is an experimental small molecule compound classified as an alpha amino acid ester and organofluorine derivative. Its chemical structure is functionally related to L-pipecolate esters and contains difluorinated and trimethoxy-substituted phenolic groups. There are no approved indications or known clinical uses for FKB‑001 as of June 2025. The mechanism of action has not been described in the available literature or databases[1][2][4]. It remains in the experimental stage with no reported clinical trial activity beyond preclinical research.

Other names

1-[2,2-difluoro-2-(3,4,5-trimethoxyphenyl)-acetyl]-piperidine-2-carboxylic acid 4-phenyl-1-(3-pyridin-3-yl-propyl)-butyl ester(S)-4-phenyl-1-[3-(3-pyridyl)propyl]butyl N-[difluoro(3,4,5-trimethoxy)acetyl]-L-pipecolate(4S)-1-phenyl-7-(pyridin-3-yl)heptan-4-yl (2S)-1-[difluoro(3,4,5-trimethoxyphenyl)acetyl]piperidine‑2‑carboxy-late